As we embark on the journey of 2024, the healthcare sector is on the brink of a profound metamorphosis, ushering...
The landscape of Medicare is undergoing a transformative change, driven by the Inflation Reduction Act of 2022 and the Centers...
The financial impact of chronic disease in the U.S. is sobering. According to the Centers for Disease Control (CDC), 90%...
Now that the Centers for Medicare & Medicaid Services (CMS) has lowered the boom on payers by dropping the star...
With the median cost of new oncology drugs over $260,000, it’s no wonder payers continue to look for opportunities to...
Momentum is building for more state legislators to have health insurance companies pay for biomarker testing for patients with cancer....
If a recent LinkedIn poll is any indication, managing high drug costs associated with cancer care continues to be a...
What are the biggest concerns in healthcare going into 2023? No surprises coming out of our recent LinkedIn survey –...